News
Our very dear friend and colleague, Prof. Dr. Ajit Kumar Padhy, passed away suddenly on the 22nd of August 2013 after suffering from a massive heart attack.
Prof Padhy was a Senior Consultant in the Singapore General Hospital, Department of Nuclear Medicine & PET since September 2005. Prior to that, he was the Head of Nuclear Medicine, IAEA, in the Division of Human Health from 1997 to 2004, and he was Faculty of Nuclear Medicine, AIIMS, New Delhi, India since the 1970’s.
Bad Berka, Germany
With over 350 participants from 30 countries representing the 5 continents, the 1st World Congress on GA68 and PRRNT marks a historical moment in the history of imaging and therapy for individuals with Neuroendocrine tumors as well as other diseases that can be imaged with GA68.
Please enjoy the photo gallery below. Viewing on an iPhone, iPad or other device that does not support flash? click here.
Dr. Richard P. Baum, was honored by the Society of Nuclear Medicine, India in Chennai on December 8, 2011 and received the AGASTHIAR AWARD for his "Life Time Contribution to The Field of Nuclear Medicine". Prof. Baum was also appointed "Visiting Professor" of the FM Medical University (Tandu Hospital) in Xi'an, Shaanxi, China where he initiated a project on Ga-68 imaging and PRRNT which will be the first place in China where THERANOSTICS will be performed. The initial effort for this
Read more: Dr. Richard P. Baum - Lifetime Contribution in...
The final program has been announced for the 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy to be held June 23rd-26th, 2011 in Bad Berka, Germany.
Please click here to download the agenda.
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers.
Published in Journal of Clinical Oncology, 2011 May 9;[Epub Ahead of Print], A Imhof, P Brunner, N Marincek, M Briel, C Schindler, H Rasch, HR Mäcke, C Rochlitz, J Müller-Brand, MA Walter
To read a review of the JCO article please visit OncologyStat (free registration is required to read the summary of findings.)